Physician profile
Antonio Daria
NPI 1447443676
$1,380.43
in general payments reported to CMS, 2019-2025
23 companies · $23.88 in 2025
The $23.88 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,183 · 2020: $158 · 2024: $15.92 · 2025: $23.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $270.11 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $148.87 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.22 | 2019-2020 | |
| Lilly USA, LLC | $132.35 | 2019-2020 | |
| Glaxosmithkline, LLC. | $128.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $75.22 | 2019 | |
| Novo Nordisk INC | $72.35 | 2019-2020 | |
| Allergan, INC. | $58.07 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.70 | 2019 | |
| Arbor Pharmaceuticals, INC. | $47.75 | 2019 | |
| Pfizer INC. | $45.15 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $28.91 | 2019 | |
| Inspire Medical Systems, INC. | $23.88 | 2025 | Inspire |
| Daiichi Sankyo INC. | $19.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.54 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $16.64 | 2020 | |
| Exact Sciences Corporation | $15.92 | 2024 | Cologuard Collection Kit |
| Avanir Pharmaceuticals, INC. | $15.31 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.73 | 2019 | |
| Horizon Therapeutics Plc | $13.85 | 2019 | |
| Astellas Pharma US INC | $13.32 | 2019 | |
| Ironwood Pharmaceuticals, INC | $12.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Daria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.